Cargando…

Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells

Introduction: The cell free ribosomal DNA (cf-rDNA) is accrued in the total pool of cell free DNA (cfDNA) in some non-cancer diseases and demonstrates DAMPs characteristics. The major research questions: (1) How does cell free rDNA content change in breast cancer; (2) What type of response in the MC...

Descripción completa

Detalles Bibliográficos
Autores principales: Malinovskaya, Elena M., Ershova, Elizaveta S., Okorokova, Natalya A., Veiko, Vladimir P., Konkova, Marina S., Kozhina, Ekaterina A., Savinova, Ekaterina A., Porokhovnik, Lev N., Kutsev, Serguey I., Veiko, Nataly N., Kostyuk, Svetlana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552851/
https://www.ncbi.nlm.nih.gov/pubmed/31205871
http://dx.doi.org/10.3389/fonc.2019.00445
_version_ 1783424683568267264
author Malinovskaya, Elena M.
Ershova, Elizaveta S.
Okorokova, Natalya A.
Veiko, Vladimir P.
Konkova, Marina S.
Kozhina, Ekaterina A.
Savinova, Ekaterina A.
Porokhovnik, Lev N.
Kutsev, Serguey I.
Veiko, Nataly N.
Kostyuk, Svetlana V.
author_facet Malinovskaya, Elena M.
Ershova, Elizaveta S.
Okorokova, Natalya A.
Veiko, Vladimir P.
Konkova, Marina S.
Kozhina, Ekaterina A.
Savinova, Ekaterina A.
Porokhovnik, Lev N.
Kutsev, Serguey I.
Veiko, Nataly N.
Kostyuk, Svetlana V.
author_sort Malinovskaya, Elena M.
collection PubMed
description Introduction: The cell free ribosomal DNA (cf-rDNA) is accrued in the total pool of cell free DNA (cfDNA) in some non-cancer diseases and demonstrates DAMPs characteristics. The major research questions: (1) How does cell free rDNA content change in breast cancer; (2) What type of response in the MCF7 breast cancer cells is caused by cf-rDNA; and (3) What type of DNA sensors (TLR9 or AIM2) is stimulated in MCF7 in response to the action of cf-rDNA? Materials and Methods: CfDNA and gDNA were isolated from the blood plasma and the cells derived from 38 breast cancer patients and 20 healthy female controls. The rDNA content in DNA was determined using non-radioactive quantitative hybridization. In order to explore the rDNA influence on MCF7 breast cancer cells, the model constructs (GC-DNAs) were applied: pBR322-rDNA plasmid (rDNA inset 5836 bp long) and pBR322 vector. ROS generation, DNA damage, cell cycle, expression of TLR9, AIM2, NF-kB, STAT3, and RNA for 44 genes affecting the cancer cell viability were evaluated. The methods used: RT-qPCR, fluorescent microscopy, immunoassay, flow cytometry, and siRNA technology. Results: The ratio R = cf-rDNA/g-rDNA for the cases was higher than for the controls (median 3.4 vs. 0.8, p < 10(−8)). In MCF7, GC-DNAs induce a ROS burst, DNA damage response, and augmentation of NF-kB and STAT3 activity. The number of the apoptotic cells decreases, while the number of cells with an instable genome (G2/M– arrest, micronuclei) increase. Expression of anti-apoptotic genes (BCL2, BCL2A1, BCL2L1, BIRC3, MDM2) is elevated, while expression of pro-apoptotic genes (BAX, BID, BAD, PMAIP1, BBC3) is lowered. The cells response for pBR322-rDNA is much more intense and develops much faster, than response for pBR322, and is realized through activation of TLR9- MyD88 - NF-kB- signaling. This difference in response speed is owing to the heightened oxidability of pBR322-rDNA and better ability to penetrate the cell. Induction of TLR9 expression in MCF7 is followed by blocking AIM2 expression. Conclusion: (1) Ribosomal DNA accumulates in cfDNA of breast cancer patients; (2) Cell free rDNA induce DNA damage response and stimulates cells survival, including cells with an instable genome; (3) Cell free rDNA triggers TLR9- MyD88- NF-kB- signaling, with significantly repressing the expression of AIM2.
format Online
Article
Text
id pubmed-6552851
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65528512019-06-14 Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells Malinovskaya, Elena M. Ershova, Elizaveta S. Okorokova, Natalya A. Veiko, Vladimir P. Konkova, Marina S. Kozhina, Ekaterina A. Savinova, Ekaterina A. Porokhovnik, Lev N. Kutsev, Serguey I. Veiko, Nataly N. Kostyuk, Svetlana V. Front Oncol Oncology Introduction: The cell free ribosomal DNA (cf-rDNA) is accrued in the total pool of cell free DNA (cfDNA) in some non-cancer diseases and demonstrates DAMPs characteristics. The major research questions: (1) How does cell free rDNA content change in breast cancer; (2) What type of response in the MCF7 breast cancer cells is caused by cf-rDNA; and (3) What type of DNA sensors (TLR9 or AIM2) is stimulated in MCF7 in response to the action of cf-rDNA? Materials and Methods: CfDNA and gDNA were isolated from the blood plasma and the cells derived from 38 breast cancer patients and 20 healthy female controls. The rDNA content in DNA was determined using non-radioactive quantitative hybridization. In order to explore the rDNA influence on MCF7 breast cancer cells, the model constructs (GC-DNAs) were applied: pBR322-rDNA plasmid (rDNA inset 5836 bp long) and pBR322 vector. ROS generation, DNA damage, cell cycle, expression of TLR9, AIM2, NF-kB, STAT3, and RNA for 44 genes affecting the cancer cell viability were evaluated. The methods used: RT-qPCR, fluorescent microscopy, immunoassay, flow cytometry, and siRNA technology. Results: The ratio R = cf-rDNA/g-rDNA for the cases was higher than for the controls (median 3.4 vs. 0.8, p < 10(−8)). In MCF7, GC-DNAs induce a ROS burst, DNA damage response, and augmentation of NF-kB and STAT3 activity. The number of the apoptotic cells decreases, while the number of cells with an instable genome (G2/M– arrest, micronuclei) increase. Expression of anti-apoptotic genes (BCL2, BCL2A1, BCL2L1, BIRC3, MDM2) is elevated, while expression of pro-apoptotic genes (BAX, BID, BAD, PMAIP1, BBC3) is lowered. The cells response for pBR322-rDNA is much more intense and develops much faster, than response for pBR322, and is realized through activation of TLR9- MyD88 - NF-kB- signaling. This difference in response speed is owing to the heightened oxidability of pBR322-rDNA and better ability to penetrate the cell. Induction of TLR9 expression in MCF7 is followed by blocking AIM2 expression. Conclusion: (1) Ribosomal DNA accumulates in cfDNA of breast cancer patients; (2) Cell free rDNA induce DNA damage response and stimulates cells survival, including cells with an instable genome; (3) Cell free rDNA triggers TLR9- MyD88- NF-kB- signaling, with significantly repressing the expression of AIM2. Frontiers Media S.A. 2019-05-30 /pmc/articles/PMC6552851/ /pubmed/31205871 http://dx.doi.org/10.3389/fonc.2019.00445 Text en Copyright © 2019 Malinovskaya, Ershova, Okorokova, Veiko, Konkova, Kozhina, Savinova, Porokhovnik, Kutsev, Veiko and Kostyuk. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Malinovskaya, Elena M.
Ershova, Elizaveta S.
Okorokova, Natalya A.
Veiko, Vladimir P.
Konkova, Marina S.
Kozhina, Ekaterina A.
Savinova, Ekaterina A.
Porokhovnik, Lev N.
Kutsev, Serguey I.
Veiko, Nataly N.
Kostyuk, Svetlana V.
Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells
title Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells
title_full Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells
title_fullStr Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells
title_full_unstemmed Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells
title_short Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells
title_sort ribosomal dna as damps signal for mcf7 cancer cells
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552851/
https://www.ncbi.nlm.nih.gov/pubmed/31205871
http://dx.doi.org/10.3389/fonc.2019.00445
work_keys_str_mv AT malinovskayaelenam ribosomaldnaasdampssignalformcf7cancercells
AT ershovaelizavetas ribosomaldnaasdampssignalformcf7cancercells
AT okorokovanatalyaa ribosomaldnaasdampssignalformcf7cancercells
AT veikovladimirp ribosomaldnaasdampssignalformcf7cancercells
AT konkovamarinas ribosomaldnaasdampssignalformcf7cancercells
AT kozhinaekaterinaa ribosomaldnaasdampssignalformcf7cancercells
AT savinovaekaterinaa ribosomaldnaasdampssignalformcf7cancercells
AT porokhovniklevn ribosomaldnaasdampssignalformcf7cancercells
AT kutsevsergueyi ribosomaldnaasdampssignalformcf7cancercells
AT veikonatalyn ribosomaldnaasdampssignalformcf7cancercells
AT kostyuksvetlanav ribosomaldnaasdampssignalformcf7cancercells